Dr. Salameh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Harbor-UCLA Medical Center
1000 W carson Street
Torrance, CA 90509Phone+1 424-306-4532Fax+1 657-213-2664
Summary
- Dr. Wael Salameh is Visiting Professor of Medicine at David Geffen School off Medicine At UCLA. He received his medical degree from Iuliu Hatieganu University of Medicine and Pharmacy and has been in either Academic Medicine or Biotech/ Pharma for 35 years. He also speaks multiple languages, including Arabic, French, Romanian, and Spanish. He is trained in Endocrinology, Diabetes and Metabolism and is experienced in Andrology and laboratory medicine. He is currently faculty at the department of General Internal Medicine and director of the continuity care clinic at Harbor-UCLA Medical Ctr.
Clinical Expertise
- Diabetes mellitus, Growth hormone deficiency, Health technology/informatics, Andrology , Laboratory medicine
Education & Training
- Los Angeles County-Harbor-UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
- University of Maryland Capital Region HealthResidency, Internal Medicine, 1984 - 1987
- University of MarylandInternship, Surgery, 1983 - 1984
- Iuliu Hatieganu University of Medicine and PharmacyClass of 1982
Certifications & Licensure
- CA State Medical License 1988 - 2025
- PA State Medical License 1990 - 1996
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- New Faculty Award Research and Education Institute ( currently Labiomed), 1998-2000
- President House Staff Association Prince George Medical Center, 1985-1986
Clinical Trials
- Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Start of enrollment: 2011 Jul 01
- Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Start of enrollment: 2012 Aug 01
- Safety and Efficacy Trial of Testosterone Undecanoate Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Hypokalemic periodic paralysis presenting as cardiac arrest.Mugdha Joshi, Wael Salameh, Janine Vintch, Elizabeth Leigh Goodman
BMJ Case Reports. 2024-11-13 - 118 citationsDihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.Ronald S. Swerdloff, Robert E Dudley, Stephanie T. Page, Christina Wang, Wael A. Salameh
Endocrine Reviews. 2017-06-01 - 44 citationsSpecificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Instit...Wael A. Salameh, Mildred M. Redor-Goldman, Nigel J. Clarke, Ruchi Mathur, Ricardo Azziz
Fertility and Sterility. 2014-04-01
Grant Support
- Hu-Ime1 Characterization And MALE InfertilityEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1999
- Hu-Ime1 Characterization And MALE InfertilityEunice Kennedy Shriver National Institute Of Child Health &Human Development1995
Professional Memberships
- Member
Other Languages
- Arabic, French, Romanian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: